Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
10,647,547
-
Total 13F shares
-
75,542
-
Share change
-
+21,068
-
Total reported value
-
$201,377
-
Price per share
-
$2.67
-
Number of holders
-
7
-
Value change
-
+$24,651
-
Number of buys
-
5
-
Number of sells
-
2
Institutional Holders of Neuraxis, INC - Common Stock, par value $0.001 per share (NRXS) as of Q4 2023
As of 31 Dec 2023 Neuraxis, INC - Common Stock, par value $0.001 per share (NRXS) had 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 75,542 shares of stock of the company.
Largest 7 holders included STIFEL FINANCIAL CORP, VANGUARD GROUP INC, ROYAL BANK OF CANADA, PARSONS CAPITAL MANAGEMENT INC/RI, Tower Research Capital LLC (TRC), WELLS FARGO & COMPANY/MN, and JPMORGAN CHASE & CO.
This table shows 7 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.